The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
Clinical trial NCT00063609 · COMPLETED
Trial details
- NCT number
- NCT00063609
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.